Up to 30% of patients with acute severe ulcerative colitis (ASUC) will require urgent colectomy despite initiation of intravenous corticosteroids and rescue therapies. Janus kinase inhibitors ...

Source Reference: Honap S, et al "Acute severe ulcerative colitis: An international delphi consensus on clinical trial design and endpoints" Clin Gastroenterol Hepatol 2024; DOI: 10.1016/j.cgh ...

Caron B, Jairath V, D’Amico F, et al. Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review. United European Gastroenterol J. Published online ...

Using tofacitinib as an adjunctive therapy to corticosteroids can improve treatment response and decrease need for rescue therapy among patients with acute severe ulcerative colitis (ASUC ...

Diversigen, Inc. and Alimentiv Inc. Announce Collaboration Agreement for Ulcerative Colitis Research Study PRESS RELEASE GlobeNewswire Jun. 25, 2020, 08:00 AM ...

Send comments and news tips to [email protected]. Cite this: Does Tofacitinib Worsen Postoperative Complications in Acute Severe Ulcerative Colitis? - Medscape - July 11, 2025.

Cite this: Edited by Shrabasti Bhattacharya. Aggressive Infliximab Dosing Shows No Added Benefit in Acute Severe Ulcerative Colitis - Medscape - November 19, 2024.

Current recommendations for the treatment of ulcerative colitis include increasingly rigorous goals beyond symptomatic or endoscopic improvement, such as the resolution of acute inflammatory cell ...